Study for Identifying Optimal Simvastatin Formulation for Uniform Time to Maximum Plasma Concentration

Summary

The inter- and intra-variability in the pharmacokinetic parameters of different formulations and doses of simvastatin in healthy subjects and in subjects with celiac disease in remission will be evaluated. Additionally, baseline values of pharmacokinetic parameters of simvastatin for both study groups will be determined.

Timeline

Start

2012-07

Primary completion

2013-07

Completion

2014-02

Outcome

Outcome not reported

Stopped (Enrollment): “Low recruitment rate”

Drugs

Indications